$BIIB·4

BIOGEN IDEC INC. · Feb 17, 8:26 PM ET

BIOGEN IDEC INC. 4

4 · BIOGEN IDEC INC. · Filed Feb 17, 2015

Insider Transaction Report

Form 4
Period: 2015-02-12
Kingsley Stuart A
EVP, Global Comm. Operations
Transactions
  • Tax Payment

    Common Stock

    2015-02-12$392.11/sh1,058$414,8527,416 total
  • Exercise/Conversion

    Common Stock

    2015-02-12+1,3558,771 total
  • Tax Payment

    Common Stock

    2015-02-12$392.11/sh639$250,5588,132 total
  • Exercise/Conversion

    Restricted Stock Unit

    2015-02-122,2464,495 total
    Exercise: $0.00Exp: 2017-02-12Common Stock (2,246 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2015-02-121,3555,315 total
    Exercise: $0.00Exp: 2017-02-12Common Stock (1,355 underlying)
  • Other

    Restricted Stock Unit

    2015-02-128674,448 total
    Exercise: $0.00Exp: 2017-02-12Common Stock (867 underlying)
  • Exercise/Conversion

    Common Stock

    2015-02-12+2,2468,474 total
Footnotes (3)
  • [F1]The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 150% of the number of shares at target payout. One-fourth of these RSUs are eligible to vest on each of the first four anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen Idec common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the average 60 calendar-day closing stock price ending on the vesting date divided by the average 60 calendar-day closing stock price on the grant date]).
  • [F2]The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen Idec common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date]).
  • [F3]This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT